April 29, 2011 | Filed under: Health,News | Posted by:
$50 worth of Avastin prevents blindness from age-related macular degeneration (AMD), and does it just as well as $2,000 worth of Lucentis, a federally funded clinical trial finds.
Posted by
on April 29, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.